CN Patent

CN111214446B — 一种供注射用法匹拉韦l-精氨酸盐冻干制剂

Assigned to Beijing Fukangren Bio Pharm Tech Co Ltd · Expires 2022-02-25 · 4y expired

What this patent protects

本发明涉及一种供注射用法匹拉韦L‑精氨酸盐冻干制剂。该冻干制剂包含法匹拉韦和L‑精氨酸，法匹拉韦与L‑精氨酸盐的摩尔比为1:1.1～1:1.3(重量比为1:22～1:1.44)；本发明还公开了一种供注射用法匹拉韦L‑精氨酸盐冻干制剂的制备方法，可保证所得的冻干制剂具有良好的复溶性，以及较高的单位装载剂量，具有良好的稳定性。

USPTO Abstract

本发明涉及一种供注射用法匹拉韦L‑精氨酸盐冻干制剂。该冻干制剂包含法匹拉韦和L‑精氨酸，法匹拉韦与L‑精氨酸盐的摩尔比为1:1.1～1:1.3(重量比为1:22～1:1.44)；本发明还公开了一种供注射用法匹拉韦L‑精氨酸盐冻干制剂的制备方法，可保证所得的冻干制剂具有良好的复溶性，以及较高的单位装载剂量，具有良好的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN111214446B
Jurisdiction
CN
Classification
—
Expires
2022-02-25
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Fukangren Bio Pharm Tech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.